Prolonged QTc Interval and Elevated Heart Rate Identify the Type 2 Diabetic Patient at High Risk for Cardiovascular Death. The Bremen Diabetes Study

B. Linnemann; H. U. Janka

doi:10.1055/s-2003-40466

Experimental and Clinical Endocrinology & Diabetes, Table of Contents

Exp Clin Endocrinol Diabetes 2003; 111(4): 215-222
DOI: 10.1055/s-2003-40466

Article

J. A. Barth Verlag in Georg Thieme Verlag Stuttgart · New York

Prolonged QTc Interval and Elevated Heart Rate Identify the Type 2 Diabetic Patient at High Risk for Cardiovascular Death. The Bremen Diabetes Study

B. Linnemann¹ , H. U. Janka¹

¹2nd Medical Clinic, Department of Internal Medicine, Central Hospital of Bremen-Nord, Bremen, Germany

Abstract

Aim

The Bremen Diabetes Study is an observation study to characterise type 2 diabetic patients at high risk for death and cardiovascular complications by routine metabolic and cardiovascular tests. The aim of the present analysis was to evaluate the prediction of QTc interval prolongation and/or heart rate for cardiovascular mortality in comparison to traditional cardiovascular risk factors.

Methods

We followed 475 type 2 diabetic patients (age 55 - 75 years; 304 women, 171 men) from a defined residential area, seen in our clinic primarily for metabolic control. Patients with coexisting micro- or macroangiopathic complications were not excluded. Outcome data were obtained for 423 subjects. QT intervals were measured in a 12 lead ECG and corrected for heart rate with Fridericia's equation [QTc = QT/RR^1/3].

Results

During the 5 year observation period 57 patients (13.5 %) died due to cardiovascular causes. In multivariate analysis we found that QTc interval prolongation (p = 0.0008), elevated heart rate (p = 0.0001), serum creatinine (p = 0.0260), smoking (p = 0.0056) and peripheral arterial disease (p = 0.0127) at baseline were independent predictors for cardiovascular death. The odds ratio was 2.7 (95 % CI 1.07 - 4.11) for QTc interval prolongation (> 421 ms) and 3.3 (95 % CI 1.33 - 8.19) for elevated heart rate (> 75/min).

Conclusion

Easily established ECG criteria such as prolonged QTc time and elevated heart rate obviously are powerful predictors of cardiovascular death in type 2 diabetic patients and are possibly superior to the traditional cardiovascular risk factors. As heart rate itself is an independent risk indicator, QTc time should be calculated by a formula (e.g. Fridericia's equation) that more accurately corrects QT for heart rate than the widely used Bazett's formula.

Key words

Type 2 diabetes - QTc interval - QTc prolongation - heart rate - cardiovascular death

Full Text

References

1 Ahnve S. Is QT interval prolongation a strong or weak predictor for cardiac death?. Circulation. 1991; 84 1862-1865
2 Ahnve S, Gilpin E, Madsen E B, Froelicher V, Henning H, Ross J. Prognostic importance of QTc interval at discharge after myocardial infarction: a multicenter study of 865 patients. Am Heart J. 1984; 108 395-400
3 Algra A, Tijssen J G, Roelandt J R, Pool J, Lubsen J. QTc prolongation measured by standard 12-lead electrocardiography is an independent risk factor for sudden death due to cardiac arrest. Circulation. 1991; 83 1888-1894
4 Bazett H C. An analysis of the time relations of electrocardiograms. Heart. 1920; 7 353-370
5 Bellavere F, Ferri M, Guarini L. et al . Prolonged QT period in diabetic autonomic neuropathy: a possible role in sudden cardiac death?. Br Heart J. 1988; 59 379-383
6 Blackburn H, Keys A, Simonson E, Rautaharju P, Punsar S. The electrocardiogram in population studies. Circulation. 1960; 21 1160-1175
7 Börger H H, von Olshausen K. EKG-Information. 6. Aufl. Darmstadt; Steinkopff 1994
8 Bravenboer B, Hendriksen P H, Dey L P, Gipsen W H, Huffelen A C, Erkelens D W. Is the corrected QT interval a reliable indicator of the severity of diabetic autonomic neuropathy?. Diabetes Care. 1993; 16 1249-1253
9 Brown D W, Giles W H, Greenlund K J, Valdez R, Croft J B. Impaired fasting glucose, diabetes mellitus, and CVD risk factors are associated with prolonged QTc duration: The Third National Health and Nutrition Examination Survey. (abstract). Circulation. 2000; 102 (Suppl II) II-872
10 Chambers J B, Sampson M J, Spirings D C, Jackson G. QT-prolongation on the ECG in diabetic autonomic neuropathy. Diabet Med. 1990; 7 105-110
11 Cowan J C, Yusoff K, Moore M. et al . Importance of lead selection in QT interval measurement. Am J Cardiol. 1988; 61 83-87
12 Dekker J M, Schouten E G, Kromhout D, Pool J. QTc prolongation predicts coronary heart disease in middle-aged and elderly men: the Zutphen Study. Circulation. 1994; 90 779-785
13 Dyer A R, Persky V, Stamler J. et al . Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies. Am J Epidemiol. 1980; 112 736-749
14 Ewing D J, Boland O, Neilson J MM, Cho C G, Clarke B F. Autonomic neuropathy, QT interval lengthening, and unexpected deaths in male diabetic patients. Diabetologia. 1991; 34 182-185
15 Filipovsky J, Ducimetiere P, Safar M E. Prognostic significance of exercise blood pressure and heart rate in middle-aged men. Hypertension. 1992; 20 333-339
16 Fridericia L S. Die Systolendauer im Elektrokardiogramm bei normalen Menschen und bei Herzkranken. Acta Med Scand. 1920; 53 469-486
17 Fuller J H, McCartney P, Jarrett R J. et al . Hyperglycemia and coronary heart disease: The Whitehall Study. J Chron Dis. 1979; 32 721-728
18 Gall M A, Sato A, Major-Pedersen A. et al . QT interval length and QT dispersion as predictors of mortality in non-insulin-dependent diabetes mellitus. (abstract). Diabetologia. 1997; 40 (Suppl 1) A461
19 Gillum R F, Makuc D M, Feldman J J. Pulse rate, coronary heart disease, and death: the NHANES I epidemiologic follow-up study. Am Heart J. 1991; 121 172-177
20 Gonin J M, Kadrofske M M, Schmaltz S, Bastyr E J, Vinik A I. Corrected QT interval prolongation as diagnostic tool for assessment of cardiac autonomic neuropathy in diabetes mellitus. Diabetes Care. 1990; 13 68-71
21 Jermendy G, Toth L, Voros P, Koltai M Z, Pogatsa G. Cardiac autonomic neuropathy and QT interval length. A follow-up study in diabetic patients. Acta Cardiol. 1991; 46 189-200
22 Jonnalagedda S M. QTc prolongation and risk of coronary heart disease. Circulation. 1995; 91 564-565
23 Kannel W B, Kannel C, Paffenbarger R S, Cupples L A. Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J. 1987; 113 1489-1494
24 Kempler P, Varadi A, Kadar E, Hermanyi Z, Tamas G. QT-Zeit-Verlängerung bei Typ-I- und Typ-II-Diabetikern: eine enge Korrelation zur autonomen kardialen Neuropathie. Diabetes und Stoffwechsel. 1992; 1 257-260
25 Lepeschkin E. The measurement of the QT interval of the electrocardiogram. Circulation. 1952; 6 378-388
26 Manson J E, Colditz G A, Stampfer M J. et al . A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med. 1991; 151 1141-1147
27 Merri M, Benhorin J, Alberti M, Locati E, Moss A J. Electrocardiographic quantitation of ventricular repolarization. Circulation. 1989; 80 1301-1308
28 Moss A J, Wojciech Z, Hall W J. et al . Effectiveness and limitations of beta blocker therapy in congenital long-QT syndrome. Circulation. 2000; 101 616-623
29 Okin P M, Devereux R B, Howard B V, Fabsitz R R, Lee E T, Welty T K. Assessment of QT interval and QT dispersion for prediction of all-cause and cardiovascular mortality in American Indians. The Strong Heart Study. Circulation. 2000; 101 61-66
30 Ong J JC, Sarma J SM, Venkataraman K, Levin S R, Singh B N. Circadian rhythmicity of heart rate and QTc interval in diabetic autonomic neuropathy: implications for the mechanism of sudden death. Am Heart J. 1993; 125 744-752
31 Palatini P, Julius S. Heart rate and the cardiovascular risk. J Hypertens. 1997; 15 3-17
32 Peters R W, Byington R P, Barker A, Yusuf S, Study Group B HAT. Prognostic value of prolonged ventricular repolarization following myocardial infarction: the BHAT experience. J Clin Epidemiol. 1990; 43 167-172
33 Puddu P E, Jouve R, Mariotti S. et al . Evaluation of 10 QT prediction formulas in 881 middle-aged men from the seven countries study: emphasis on the cubic root Fridericia's equation. J Electrocardiol. 1988; 21 219-229
34 Roden D M, Lazzara R, Rosen M, Schwartz P J, Towbin J, Vincent G M, for the Foundation Task Force on S ADSLQTS. Multiple mechanisms in the long-QT-syndrome: current knowledge, gaps, and future directions. Circulation. 1996; 94 1996-2012
35 Rossing P, Breum L, Major-Pedersen A. et al . QT interval predicts mortality in type I diabetic patients. (abstract). Diabetologia. 1998; 41 (Suppl 1) A30
36 Sagie A, Larson M G, Goldberg R J, Bengtson J R, Levy D. An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study). Am J Cardiol. 1992; 70 797-801
37 Sawicki P T, Dähne R, Bender R, Berger M. Prolonged QT interval as a predictor of mortality in diabetic nephropathy. Diabetologia. 1996; 39 77-81
38 Schnell O, Stenner T, Standl E, Haslbeck M. Zum diagnostischen Wert des frequenzkorrigierten QT-Intervalls bei langjährigem Typ-I-Diabetes mellitus. Dtsch Med Wschr. 1996; 121 819-822
39 Schouten E G, Dekker J M, Meppelink P, Kok F J, Vandenbroucke J P, Pool J. QT interval prolongation predicts cardiovascular mortality in an apparently healthy population. Circulation. 1991; 84 1516-1523
40 Schwartz P J, Wolf S. QT interval prolongation as predictor of sudden death in patients with myocardial infarction. Circulation. 1978; 57 1074-1077
41 Sivieri R, Veglio M, Chinaglia A, Scaglione P, Cavallo-Perin P. Prevalence of QT prolongation in a type I diabetic population and its association with autonomic neuropathy. Diabet Med. 1993; 10 920-924
42 Spodick D H, Rifkin R D, Rajasingh M C. Effect of self-correlation on the relation between QT interval and cardiac cycle length. Am Heart J. 1990; 120 157-160
43 The Sudden Arrhythmia Death Syndrome Foundation .An overview of the inherited long QT syndrome. http://www.sads.org .
44 Veglio M, Borra M, Stevens L K, Fuller J H, Perin P C. The relation between QTc interval prolongation and diabetic complications. The EURODIAB IDDM Complication Study Group. Diabetologia. 1999; 42 68-75
45 Veglio M, Chinaglia A, Borra M, Cavallo-Perin P. Does abnormal QT interval prolongation reflect autonomic dysfunction in diabetic patients? QTc interval measure versus standardized tests in diabetic neuropathy. Diabet Med. 1995; 12 302-306
46 Viskin S. Long QT syndromes and torsade de pointes. Lancet. 1999; 354 1625-1633

Dr. Birgit Linnemann

2nd Medical Clinic, Department of Internal Medicine, Central Hospital of Bremen-Nord

Hammersbecker Straße 228

28755 Bremen

Germany

Phone: + 4942166061301

Fax: + 49 4 21 66 06 16 79

Email: Birgit.Linnemann@zkhnord.de